Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned

NCT03342859 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
10
Enrollment
INDUSTRY
Sponsor class

Stopped Due to findings in the preclinical carcinogenicity studies for vilaprisan (BAY1002670)

Conditions

Interventions

Sponsor

Bayer